The global breast biopsy devices market size was estimated at USD 3.52 billion in 2025 and is projected to reach USD 5.60 billion by 2033, growing at a CAGR of 6.04% from 2026 to 2033. The market is primarily driven by the rising global incidence of breast cancer and increasing demand for early and accurate diagnosis. ![Breast Biopsy Devices Market]( "Breast Biopsy Devices Market")
The expansion of national screening programs and greater awareness of routine mammography are leading to more abnormalities being detected, requiring biopsy confirmation. Technological advancements in minimally invasive and image-guided biopsy techniques are improving diagnostic precision and patient comfort.
In addition, the expansion of healthcare infrastructure and outpatient care facilities is driving higher procedural volumes worldwide. According to Breastcancer.org, in 2026, it is estimated that about 42,140 women in the U.S. will die from breast cancer, highlighting the continuing mortality burden of the disease despite advances in early detection and treatment.
The increasing global burden of breast cancer is a major driver of the breast biopsy devices industry. As the number of newly diagnosed cases continues to rise worldwide, the demand for accurate and timely diagnostic procedures has grown significantly. Breast biopsy devices play a critical role in confirming malignancy in cases with abnormal imaging findings. Consequently, higher incidence rates directly contribute to increased procedure volumes, driving sustained growth in the breast biopsy devices industry. According to Breastcancer.org, about 1 in 8 women in the U.S. (approximately 13%) will be diagnosed with invasive breast cancer during their lifetime. Each year, breast cancer represents roughly 30% of all newly diagnosed cancers among U.S. women, making it one of the most common cancers affecting women. These statistics highlight the significant impact and ongoing burden of breast cancer nationwide. The table below shows key breast cancer statistics.
This product will be delivered within 1-3 business days.
The expansion of national screening programs and greater awareness of routine mammography are leading to more abnormalities being detected, requiring biopsy confirmation. Technological advancements in minimally invasive and image-guided biopsy techniques are improving diagnostic precision and patient comfort.
In addition, the expansion of healthcare infrastructure and outpatient care facilities is driving higher procedural volumes worldwide. According to Breastcancer.org, in 2026, it is estimated that about 42,140 women in the U.S. will die from breast cancer, highlighting the continuing mortality burden of the disease despite advances in early detection and treatment.
The increasing global burden of breast cancer is a major driver of the breast biopsy devices industry. As the number of newly diagnosed cases continues to rise worldwide, the demand for accurate and timely diagnostic procedures has grown significantly. Breast biopsy devices play a critical role in confirming malignancy in cases with abnormal imaging findings. Consequently, higher incidence rates directly contribute to increased procedure volumes, driving sustained growth in the breast biopsy devices industry. According to Breastcancer.org, about 1 in 8 women in the U.S. (approximately 13%) will be diagnosed with invasive breast cancer during their lifetime. Each year, breast cancer represents roughly 30% of all newly diagnosed cancers among U.S. women, making it one of the most common cancers affecting women. These statistics highlight the significant impact and ongoing burden of breast cancer nationwide. The table below shows key breast cancer statistics.
Global Breast Biopsy Devices Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global breast biopsy devices market report based on product, procedure, guidance technology, end use, and region:Product Outlook (Revenue, USD Million, 2021-2033)
- Biopsy Guidance Systems
- Biopsy Drivers & Handpieces
- Biopsy Tables
- Biopsy Consumables
- By Shape/Design
- Standard Geometric Markers
- Advanced Anchoring Markers"U" Shape" Shape
- 3D / Expandable Markers
- Localization Systems
- Other Consumables
Procedure Outlook (Revenue, USD Million, 2021-2033)
- Vacuum-Assisted Biopsy (VAB)
- Core Needle Biopsy (CNB)
- Fine Needle Aspiration Biopsy (FNAB)
- Surgical (Open) Biopsy
- Liquid Biopsy
Guidance Technology Outlook (Revenue, USD Million, 2021-2033)
- Ultrasound-Guided
- Mammography / Stereotactic-Guided
- MRI-Guided
End Use Outlook (Revenue, USD Million; 2021-2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Specialized Breast Care Centers
- Diagnostic Centers/Imaging Centers
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Product
1.1.2. Procedure
1.1.3. Guidance Technology
1.1.4. End Use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
1.1.1. Product
1.1.2. Procedure
1.1.3. Guidance Technology
1.1.4. End Use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Market Definitions
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.5. Details of primary research
1.5.1. Data for primary interviews in North America
1.5.2. Data for primary interviews in Europe
1.5.3. Data for primary interviews in Asia Pacific
1.5.4. Data for primary interviews in Latin America
1.5.5. Data for Primary interviews in MEA
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. Research Scope and Assumptions
1.8.1. List of Secondary Sources
1.8.2. List of Primary Sources
1.8.3. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Breast Biopsy Devices Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing burden of breast cancer
3.2.1.2. Expansion of breast cancer screening programs
3.2.1.3. Technological advancements in imaging-guided biopsy
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of advanced biopsy technologies
3.2.2.2. Limited access to diagnostic facilities in low-resource settings
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of screening programs in emerging economies
3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
3.2.3.3. Integration with next-generation imaging and AI
3.2.3.4. Expansion of outpatient and ambulatory care
3.2.3.5. Rising demand for personalized and precision diagnostics
3.2.4. Market Challenge Analysis
3.2.4.1. Patient anxiety and procedure hesitation
3.2.4.2. Limited skilled workforce
3.3. Breast Biopsy Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Increasing burden of breast cancer
3.2.1.2. Expansion of breast cancer screening programs
3.2.1.3. Technological advancements in imaging-guided biopsy
3.2.2. Market Restraints Analysis
3.2.2.1. High cost of advanced biopsy technologies
3.2.2.2. Limited access to diagnostic facilities in low-resource settings
3.2.3. Market Opportunity Analysis
3.2.3.1. Expansion of screening programs in emerging economies
3.2.3.2. Growth of minimally invasive and rapid diagnostic technologies
3.2.3.3. Integration with next-generation imaging and AI
3.2.3.4. Expansion of outpatient and ambulatory care
3.2.3.5. Rising demand for personalized and precision diagnostics
3.2.4. Market Challenge Analysis
3.2.4.1. Patient anxiety and procedure hesitation
3.2.4.2. Limited skilled workforce
3.3. Breast Biopsy Devices Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal landscape
Chapter 4. Breast Biopsy Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.3.1. Biopsy Guidance Systems
4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2. Biopsy Drivers & Handpieces
4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3. Core needle biopsy (CNB) guns
4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.2. Automated
4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.3. Semi-automated
4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3. Biopsy tables
4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.2. Prone tables
4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.3. Upright/add-on tables
4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4. Biopsy consumables
4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.2. Needles & probes
4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3. Site markers & clips
4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.2. By shape/design
4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3. Standard geometric markers
4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.2. Ring
4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.3. Cross
4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.4. Ribbon
4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.5. Others
4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4. Advanced anchoring markers
4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.2. Anchor
4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.3. Wing, "U" shape
4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.4. "Q" shape
4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5. 3D / expandable markers
4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.2. 3D ribbon
4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.3. 3D sphere
4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.4. 3D Mesh
4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4. Localization systems
4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.2. Traditional wires
4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.3. Wireless Seeds-RFID/magnetic
4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.5. Other Consumables
4.3.5.1. Other Consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.2. Global Breast Biopsy Devices Market: Product Movement Analysis, 2025 & 2033 (USD Million)
4.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.3.1. Biopsy Guidance Systems
4.3.1.1. Biopsy guidance systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2. Biopsy Drivers & Handpieces
4.3.2.1. Biopsy drivers & handpieces market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.2. Vacuum-assisted biopsy (VAB) drivers
4.3.2.2.1. Vacuum-assisted biopsy (VAB) drivers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3. Core needle biopsy (CNB) guns
4.3.2.3.1. Core needle biopsy (CNB) guns market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.2. Automated
4.3.2.3.2.1. Automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.2.3.3. Semi-automated
4.3.2.3.3.1. Semi-automated market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3. Biopsy tables
4.3.3.1. Biopsy tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.2. Prone tables
4.3.3.2.1. Prone tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.3.3. Upright/add-on tables
4.3.3.3.1. Upright/add-on tables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4. Biopsy consumables
4.3.4.1. Biopsy consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.2. Needles & probes
4.3.4.2.1. Needles & probes market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3. Site markers & clips
4.3.4.3.1. Site markers & clips market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.2. By shape/design
4.3.4.3.2.1. By shape/design market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3. Standard geometric markers
4.3.4.3.3.1. Standard geometric markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.2. Ring
4.3.4.3.3.2.1. Ring market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.3. Cross
4.3.4.3.3.3.1. Cross market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.4. Ribbon
4.3.4.3.3.4.1. Ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.3.5. Others
4.3.4.3.3.5.1. Others markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4. Advanced anchoring markers
4.3.4.3.4.1. Advanced anchoring markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.2. Anchor
4.3.4.3.4.2.1. Anchor markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.3. Wing, "U" shape
4.3.4.3.4.3.1. Wing, "U" shape market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.4.4. "Q" shape
4.3.4.3.4.4.1. "Q" shape markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5. 3D / expandable markers
4.3.4.3.5.1. 3D / expandable markers market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.2. 3D ribbon
4.3.4.3.5.2.1. 3D ribbon market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.3. 3D sphere
4.3.4.3.5.3.1. 3D Sphere market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.3.5.4. 3D Mesh
4.3.4.3.5.4.1. 3D Mesh market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4. Localization systems
4.3.4.4.1. Localization systems market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.2. Traditional wires
4.3.4.4.2.1. Traditional wires market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.4.4.3. Wireless Seeds-RFID/magnetic
4.3.4.4.3.1. Wireless seeds-RFID/magnetic market revenue estimates and forecasts, 2021-2033 (USD Million)
4.3.5. Other Consumables
4.3.5.1. Other Consumables market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Breast Biopsy Devices Market: Procedure Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Breast Biopsy Devices Market: Procedure Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
5.3.1. Vacuum-Assisted Biopsy (VAB)
5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.2. Core Needle Biopsy (CNB)
5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.3. Fine Needle Aspiration Biopsy (FNAB)
5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.4. Surgical (Open) Biopsy
5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.5. Liquid Biopsy
5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
5.2. Global Breast Biopsy Devices Market: Procedure Movement Analysis, 2025 & 2033 (USD Million)
5.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
5.3.1. Vacuum-Assisted Biopsy (VAB)
5.3.1.1. Vacuum-assisted biopsy (VAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.2. Core Needle Biopsy (CNB)
5.3.2.1. Core needle biopsy (CNB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.3. Fine Needle Aspiration Biopsy (FNAB)
5.3.3.1. Fine needle aspiration biopsy (FNAB) market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.4. Surgical (Open) Biopsy
5.3.4.1. Surgical (open) biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
5.3.5. Liquid Biopsy
5.3.5.1. Liquid biopsy market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 6. Breast Biopsy Devices Market: Guidance Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
6.3.1. Ultrasound-Guided
6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.2. Mammography / Stereotactic-Guided
6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.3. MRI-Guided
6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.2. Global Breast Biopsy Devices Market: Guidance Technology Movement Analysis, 2025 & 2033 (USD Million)
6.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by Guidance Technology, 2021 to 2033 (USD Million)
6.3.1. Ultrasound-Guided
6.3.1.1. Ultrasound-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.2. Mammography / Stereotactic-Guided
6.3.2.1. Mammography / stereotactic-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
6.3.3. MRI-Guided
6.3.3.1. MRI-guided market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Breast Biopsy Devices Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
7.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
7.3.1. Hospitals
7.3.1.1. Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.2. Ambulatory Surgical Centers (ASCs)
7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.3. Specialized Breast Care Centers
7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.4. Diagnostic Centers/Imaging Centers
7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021-2033 (USD Million)
7.2. Global Breast Biopsy Devices Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
7.3. Global Breast Biopsy Devices Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
7.3.1. Hospitals
7.3.1.1. Hospitals market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.2. Ambulatory Surgical Centers (ASCs)
7.3.2.1. Ambulatory surgical centers (ASCs) market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.3. Specialized Breast Care Centers
7.3.3.1. Specialized breast care centers market revenue estimates and forecasts, 2021-2033 (USD Million)
7.3.4. Diagnostic Centers/Imaging Centers
7.3.4.1. Diagnostic centers/imaging centers market revenue estimates and forecasts, 2021-2033 (USD Million)
Chapter 8. Breast Biopsy Devices Market: Regional Estimates & Trend Analysis by Product, Procedure, Guidance Technology, and End Use
8.1. Regional Dashboard
8.2. Market Size and Trend Analysis, 2021 to 2033
8.3. North America
8.3.1. North America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory framework
8.3.2.4. Reimbursement scenario
8.3.2.5. U.S. breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory framework
8.3.3.4. Reimbursement scenario
8.3.3.5. Canada breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory framework
8.3.4.4. Reimbursement scenario
8.3.4.5. Mexico breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4. Europe
8.4.1. Europe breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.2. UK
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. UK breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. Germany breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.4. France
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory framework
8.4.4.4. Reimbursement scenario
8.4.4.5. France breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key country dynamics
8.4.5.2. Competitive scenario
8.4.5.3. Regulatory framework
8.4.5.4. Reimbursement scenario
8.4.5.5. Italy breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key country dynamics
8.4.6.2. Competitive scenario
8.4.6.3. Regulatory framework
8.4.6.4. Reimbursement scenario
8.4.6.5. Spain breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Competitive scenario
8.4.7.3. Regulatory framework
8.4.7.4. Reimbursement scenario
8.4.7.5. Sweden breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Competitive scenario
8.4.8.3. Regulatory framework
8.4.8.4. Reimbursement scenario
8.4.8.5. Denmark breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.9. Norway
8.4.9.1. Key country dynamics
8.4.9.2. Competitive scenario
8.4.9.3. Regulatory framework
8.4.9.4. Reimbursement scenario
8.4.9.5. Norway breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. China breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.3. Japan
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Japan breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.4. India
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. India breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. South Korea breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.6. Australia
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Australia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.7. Thailand
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Thailand breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6. Latin America
8.6.1. Latin America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6.2. Brazil
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Brazil breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. Argentina breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7. Middle East and Africa
8.7.1. Middle East and Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.2. South Africa
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. South Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement scenario
8.7.3.5. Saudi Arabia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.4. UAE
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement scenario
8.7.4.5. UAE breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Reimbursement scenario
8.7.5.5. Kuwait breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.2. Market Size and Trend Analysis, 2021 to 2033
8.3. North America
8.3.1. North America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.2. U.S.
8.3.2.1. Key country dynamics
8.3.2.2. Competitive scenario
8.3.2.3. Regulatory framework
8.3.2.4. Reimbursement scenario
8.3.2.5. U.S. breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.3. Canada
8.3.3.1. Key country dynamics
8.3.3.2. Competitive scenario
8.3.3.3. Regulatory framework
8.3.3.4. Reimbursement scenario
8.3.3.5. Canada breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.3.4. Mexico
8.3.4.1. Key country dynamics
8.3.4.2. Competitive scenario
8.3.4.3. Regulatory framework
8.3.4.4. Reimbursement scenario
8.3.4.5. Mexico breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4. Europe
8.4.1. Europe breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.2. UK
8.4.2.1. Key country dynamics
8.4.2.2. Competitive scenario
8.4.2.3. Regulatory framework
8.4.2.4. Reimbursement scenario
8.4.2.5. UK breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.3. Germany
8.4.3.1. Key country dynamics
8.4.3.2. Competitive scenario
8.4.3.3. Regulatory framework
8.4.3.4. Reimbursement scenario
8.4.3.5. Germany breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.4. France
8.4.4.1. Key country dynamics
8.4.4.2. Competitive scenario
8.4.4.3. Regulatory framework
8.4.4.4. Reimbursement scenario
8.4.4.5. France breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.5. Italy
8.4.5.1. Key country dynamics
8.4.5.2. Competitive scenario
8.4.5.3. Regulatory framework
8.4.5.4. Reimbursement scenario
8.4.5.5. Italy breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.6. Spain
8.4.6.1. Key country dynamics
8.4.6.2. Competitive scenario
8.4.6.3. Regulatory framework
8.4.6.4. Reimbursement scenario
8.4.6.5. Spain breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Competitive scenario
8.4.7.3. Regulatory framework
8.4.7.4. Reimbursement scenario
8.4.7.5. Sweden breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Competitive scenario
8.4.8.3. Regulatory framework
8.4.8.4. Reimbursement scenario
8.4.8.5. Denmark breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.4.9. Norway
8.4.9.1. Key country dynamics
8.4.9.2. Competitive scenario
8.4.9.3. Regulatory framework
8.4.9.4. Reimbursement scenario
8.4.9.5. Norway breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5. Asia Pacific
8.5.1. Asia Pacific breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Competitive scenario
8.5.2.3. Regulatory framework
8.5.2.4. Reimbursement scenario
8.5.2.5. China breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.3. Japan
8.5.3.1. Key country dynamics
8.5.3.2. Competitive scenario
8.5.3.3. Regulatory framework
8.5.3.4. Reimbursement scenario
8.5.3.5. Japan breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.4. India
8.5.4.1. Key country dynamics
8.5.4.2. Competitive scenario
8.5.4.3. Regulatory framework
8.5.4.4. Reimbursement scenario
8.5.4.5. India breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Competitive scenario
8.5.5.3. Regulatory framework
8.5.5.4. Reimbursement scenario
8.5.5.5. South Korea breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.6. Australia
8.5.6.1. Key country dynamics
8.5.6.2. Competitive scenario
8.5.6.3. Regulatory framework
8.5.6.4. Reimbursement scenario
8.5.6.5. Australia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.5.7. Thailand
8.5.7.1. Key country dynamics
8.5.7.2. Competitive scenario
8.5.7.3. Regulatory framework
8.5.7.4. Reimbursement scenario
8.5.7.5. Thailand breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6. Latin America
8.6.1. Latin America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6.2. Brazil
8.6.2.1. Key country dynamics
8.6.2.2. Competitive scenario
8.6.2.3. Regulatory framework
8.6.2.4. Reimbursement scenario
8.6.2.5. Brazil breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.6.3. Argentina
8.6.3.1. Key country dynamics
8.6.3.2. Competitive scenario
8.6.3.3. Regulatory framework
8.6.3.4. Reimbursement scenario
8.6.3.5. Argentina breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7. Middle East and Africa
8.7.1. Middle East and Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.2. South Africa
8.7.2.1. Key country dynamics
8.7.2.2. Competitive scenario
8.7.2.3. Regulatory framework
8.7.2.4. Reimbursement scenario
8.7.2.5. South Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.3. Saudi Arabia
8.7.3.1. Key country dynamics
8.7.3.2. Competitive scenario
8.7.3.3. Regulatory framework
8.7.3.4. Reimbursement scenario
8.7.3.5. Saudi Arabia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.4. UAE
8.7.4.1. Key country dynamics
8.7.4.2. Competitive scenario
8.7.4.3. Regulatory framework
8.7.4.4. Reimbursement scenario
8.7.4.5. UAE breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
8.7.5. Kuwait
8.7.5.1. Key country dynamics
8.7.5.2. Competitive scenario
8.7.5.3. Regulatory framework
8.7.5.4. Reimbursement scenario
8.7.5.5. Kuwait breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Market Share Analysis, 2025
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.5.6. Company Profiles
9.5.7. Hologic, Inc.
9.5.7.1. Company overview
9.5.7.2. Financial performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Mammotome (Danaher)
9.5.8.1. Company overview
9.5.8.2. Financial performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic initiatives
9.5.9. BD
9.5.9.1. Company overview
9.5.9.2. Financial performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Argon Medical
9.5.10.1. Company overview
9.5.10.2. Financial performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic initiatives
9.5.11. Merit Medical Systems
9.5.11.1. Company overview
9.5.11.2. Financial performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic initiatives
9.5.12. GE HealthCare
9.5.12.1. Company overview
9.5.12.2. Financial performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic initiatives
9.5.13. Cook Medical
9.5.13.1. Company overview
9.5.13.2. Financial performance
9.5.13.3. Product Benchmarking
9.5.13.4. Strategic initiatives
9.5.14. MOLLI Surgical (Stryker)
9.5.14.1. Company overview
9.5.14.2. Financial performance
9.5.14.3. Product Benchmarking
9.5.14.4. Strategic initiatives
9.5.15. Planmed Oy
9.5.15.1. Company overview
9.5.15.2. Financial performance
9.5.15.3. Product Benchmarking
9.5.15.4. Strategic initiatives
9.5.16. Metaltronica Spa
9.5.16.1. Company overview
9.5.16.2. Financial performance
9.5.16.3. Product Benchmarking
9.5.16.4. Strategic initiatives
9.5.17. Trivitron Healthcare
9.5.17.1. Company overview
9.5.17.2. Financial performance
9.5.17.3. Product Benchmarking
9.5.17.4. Strategic initiatives
9.5.18. Siemens Healthineers
9.5.18.1. Company overview
9.5.18.2. Financial performance
9.5.18.3. Product Benchmarking
9.5.18.4. Strategic initiatives
9.5.19. Fujifilm Healthcare
9.5.19.1. Company overview
9.5.19.2. Financial performance
9.5.19.3. Product Benchmarking
9.5.19.4. Strategic initiatives
9.5.20. INRAD
9.5.20.1. Company overview
9.5.20.2. Financial performance
9.5.20.3. Product Benchmarking
9.5.20.4. Strategic initiatives
9.5.21. SteryLab
9.5.21.1. Company overview
9.5.21.2. Financial performance
9.5.21.3. Product Benchmarking
9.5.21.4. Strategic initiatives
9.5.22. Resitu Medical
9.5.22.1. Company overview
9.5.22.2. Financial performance
9.5.22.3. Product Benchmarking
9.5.22.4. Strategic initiatives
9.5.23. TransMed7, LLC.
9.5.23.1. Company overview
9.5.23.2. Financial performance
9.5.23.3. Product Benchmarking
9.5.23.4. Strategic initiatives
9.2. Company Categorization
9.3. Company Market Share Analysis, 2025
9.4. Company Heat Map Analysis
9.5. Strategy Mapping
9.5.1. Expansion
9.5.2. Mergers & Acquisition
9.5.3. Partnerships & Collaborations
9.5.4. New Product Launches
9.5.5. Research And Development
9.5.6. Company Profiles
9.5.7. Hologic, Inc.
9.5.7.1. Company overview
9.5.7.2. Financial performance
9.5.7.3. Product Benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Mammotome (Danaher)
9.5.8.1. Company overview
9.5.8.2. Financial performance
9.5.8.3. Product Benchmarking
9.5.8.4. Strategic initiatives
9.5.9. BD
9.5.9.1. Company overview
9.5.9.2. Financial performance
9.5.9.3. Product Benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Argon Medical
9.5.10.1. Company overview
9.5.10.2. Financial performance
9.5.10.3. Product Benchmarking
9.5.10.4. Strategic initiatives
9.5.11. Merit Medical Systems
9.5.11.1. Company overview
9.5.11.2. Financial performance
9.5.11.3. Product Benchmarking
9.5.11.4. Strategic initiatives
9.5.12. GE HealthCare
9.5.12.1. Company overview
9.5.12.2. Financial performance
9.5.12.3. Product Benchmarking
9.5.12.4. Strategic initiatives
9.5.13. Cook Medical
9.5.13.1. Company overview
9.5.13.2. Financial performance
9.5.13.3. Product Benchmarking
9.5.13.4. Strategic initiatives
9.5.14. MOLLI Surgical (Stryker)
9.5.14.1. Company overview
9.5.14.2. Financial performance
9.5.14.3. Product Benchmarking
9.5.14.4. Strategic initiatives
9.5.15. Planmed Oy
9.5.15.1. Company overview
9.5.15.2. Financial performance
9.5.15.3. Product Benchmarking
9.5.15.4. Strategic initiatives
9.5.16. Metaltronica Spa
9.5.16.1. Company overview
9.5.16.2. Financial performance
9.5.16.3. Product Benchmarking
9.5.16.4. Strategic initiatives
9.5.17. Trivitron Healthcare
9.5.17.1. Company overview
9.5.17.2. Financial performance
9.5.17.3. Product Benchmarking
9.5.17.4. Strategic initiatives
9.5.18. Siemens Healthineers
9.5.18.1. Company overview
9.5.18.2. Financial performance
9.5.18.3. Product Benchmarking
9.5.18.4. Strategic initiatives
9.5.19. Fujifilm Healthcare
9.5.19.1. Company overview
9.5.19.2. Financial performance
9.5.19.3. Product Benchmarking
9.5.19.4. Strategic initiatives
9.5.20. INRAD
9.5.20.1. Company overview
9.5.20.2. Financial performance
9.5.20.3. Product Benchmarking
9.5.20.4. Strategic initiatives
9.5.21. SteryLab
9.5.21.1. Company overview
9.5.21.2. Financial performance
9.5.21.3. Product Benchmarking
9.5.21.4. Strategic initiatives
9.5.22. Resitu Medical
9.5.22.1. Company overview
9.5.22.2. Financial performance
9.5.22.3. Product Benchmarking
9.5.22.4. Strategic initiatives
9.5.23. TransMed7, LLC.
9.5.23.1. Company overview
9.5.23.2. Financial performance
9.5.23.3. Product Benchmarking
9.5.23.4. Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America breast biopsy devices market, by region 2021-2033 (USD Million)
Table 3 North America breast biopsy devices market, by product 2021-2033 (USD Million)
Table 4 North America breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 5 North America breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 6 North America breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 7 U.S. breast biopsy devices market, by product 2021-2033 (USD Million)
Table 8 U.S. breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 9 U.S. breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 10 U.S. breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 11 Canada breast biopsy devices market, by product 2021-2033 (USD Million)
Table 12 Canada breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 13 Canada breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 14 Canada breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 15 Mexico breast biopsy devices market, by product 2021-2033 (USD Million)
Table 16 Mexico breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 17 Mexico breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 18 Mexico breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 19 Europe breast biopsy devices market, by region 2021-2033 (USD Million)
Table 20 Europe breast biopsy devices market, by product 2021-2033 (USD Million)
Table 21 Europe breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 22 Europe breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 23 Europe breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 24 Germany breast biopsy devices market, by product 2021-2033 (USD Million)
Table 25 Germany breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 26 Germany breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 27 Germany breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 28 UK breast biopsy devices market, by product 2021-2033 (USD Million)
Table 29 UK breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 30 UK breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 31 UK breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 32 France breast biopsy devices market, by product 2021-2033 (USD Million)
Table 33 France breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 34 France breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 35 France breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 36 Italy breast biopsy devices market, by product 2021-2033 (USD Million)
Table 37 Italy breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 38 Italy breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 39 Italy breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 40 Spain breast biopsy devices market, by product 2021-2033 (USD Million)
Table 41 Spain breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 42 Spain breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 43 Spain breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 44 Denmark breast biopsy devices market, by product 2021-2033 (USD Million)
Table 45 Denmark breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 46 Denmark breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 47 Denmark breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 48 Sweden breast biopsy devices market, by product 2021-2033 (USD Million)
Table 49 Sweden breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 50 Sweden breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 51 Sweden breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 52 Norway breast biopsy devices market, by product 2021-2033 (USD Million)
Table 53 Norway breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 54 Norway breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 55 Norway breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 56 Asia Pacific breast biopsy devices market, by region 2021-2033 (USD Million)
Table 57 Asia Pacific breast biopsy devices market, by product 2021-2033 (USD Million)
Table 58 Asia Pacific breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 59 Asia Pacific breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 60 Asia Pacific breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 61 China breast biopsy devices market, by product 2021-2033 (USD Million)
Table 62 China breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 63 China breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 64 China breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 65 Japan breast biopsy devices market, by product 2021-2033 (USD Million)
Table 66 Japan breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 67 Japan breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 68 Japan breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 69 India breast biopsy devices market, by product 2021-2033 (USD Million)
Table 70 India breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 71 India breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 72 India breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 73 South Korea breast biopsy devices market, by product 2021-2033 (USD Million)
Table 74 South Korea breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 75 South Korea breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 76 South Korea breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 77 Australia breast biopsy devices market, by product 2021-2033 (USD Million)
Table 78 Australia breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 79 Australia breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 80 Australia breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 81 Thailand breast biopsy devices market, by product 2021-2033 (USD Million)
Table 82 Thailand breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 83 Thailand breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 84 Thailand breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 85 Latin America breast biopsy devices market, by region 2021-2033 (USD Million)
Table 86 Latin America breast biopsy devices market, by product 2021-2033 (USD Million)
Table 87 Latin America breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 88 Latin America breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 89 Latin America breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 90 Brazil breast biopsy devices market, by product 2021-2033 (USD Million)
Table 91 Brazil breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 92 Brazil breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 93 Brazil breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 94 Argentina breast biopsy devices market, by product 2021-2033 (USD Million)
Table 95 Argentina breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 96 Argentina breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 97 Argentina breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 98 MEA breast biopsy devices market, by region 2021-2033 (USD Million)
Table 99 MEA breast biopsy devices market, by product 2021-2033 (USD Million)
Table 100 MEA breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 101 MEA breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 102 MEA breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 103 South Africa breast biopsy devices market, by product 2021-2033 (USD Million)
Table 104 South Africa breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 105 South Africa breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 106 South Africa breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 107 Saudi Arabia breast biopsy devices market, by product 2021-2033 (USD Million)
Table 108 Saudi Arabia breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 109 Saudi Arabia breast biopsy devices market, by guidance technology (USD Million)
Table 110 Saudi Arabia breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 111 UAE breast biopsy devices market, by product 2021-2033 (USD Million)
Table 112 UAE breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 113 UAE breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 114 UAE breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 115 Kuwait breast biopsy devices market, by product 2021-2033 (USD Million)
Table 116 Kuwait breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 117 Kuwait breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 118 Kuwait breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 2 North America breast biopsy devices market, by region 2021-2033 (USD Million)
Table 3 North America breast biopsy devices market, by product 2021-2033 (USD Million)
Table 4 North America breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 5 North America breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 6 North America breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 7 U.S. breast biopsy devices market, by product 2021-2033 (USD Million)
Table 8 U.S. breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 9 U.S. breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 10 U.S. breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 11 Canada breast biopsy devices market, by product 2021-2033 (USD Million)
Table 12 Canada breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 13 Canada breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 14 Canada breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 15 Mexico breast biopsy devices market, by product 2021-2033 (USD Million)
Table 16 Mexico breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 17 Mexico breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 18 Mexico breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 19 Europe breast biopsy devices market, by region 2021-2033 (USD Million)
Table 20 Europe breast biopsy devices market, by product 2021-2033 (USD Million)
Table 21 Europe breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 22 Europe breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 23 Europe breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 24 Germany breast biopsy devices market, by product 2021-2033 (USD Million)
Table 25 Germany breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 26 Germany breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 27 Germany breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 28 UK breast biopsy devices market, by product 2021-2033 (USD Million)
Table 29 UK breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 30 UK breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 31 UK breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 32 France breast biopsy devices market, by product 2021-2033 (USD Million)
Table 33 France breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 34 France breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 35 France breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 36 Italy breast biopsy devices market, by product 2021-2033 (USD Million)
Table 37 Italy breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 38 Italy breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 39 Italy breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 40 Spain breast biopsy devices market, by product 2021-2033 (USD Million)
Table 41 Spain breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 42 Spain breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 43 Spain breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 44 Denmark breast biopsy devices market, by product 2021-2033 (USD Million)
Table 45 Denmark breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 46 Denmark breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 47 Denmark breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 48 Sweden breast biopsy devices market, by product 2021-2033 (USD Million)
Table 49 Sweden breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 50 Sweden breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 51 Sweden breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 52 Norway breast biopsy devices market, by product 2021-2033 (USD Million)
Table 53 Norway breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 54 Norway breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 55 Norway breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 56 Asia Pacific breast biopsy devices market, by region 2021-2033 (USD Million)
Table 57 Asia Pacific breast biopsy devices market, by product 2021-2033 (USD Million)
Table 58 Asia Pacific breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 59 Asia Pacific breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 60 Asia Pacific breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 61 China breast biopsy devices market, by product 2021-2033 (USD Million)
Table 62 China breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 63 China breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 64 China breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 65 Japan breast biopsy devices market, by product 2021-2033 (USD Million)
Table 66 Japan breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 67 Japan breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 68 Japan breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 69 India breast biopsy devices market, by product 2021-2033 (USD Million)
Table 70 India breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 71 India breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 72 India breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 73 South Korea breast biopsy devices market, by product 2021-2033 (USD Million)
Table 74 South Korea breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 75 South Korea breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 76 South Korea breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 77 Australia breast biopsy devices market, by product 2021-2033 (USD Million)
Table 78 Australia breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 79 Australia breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 80 Australia breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 81 Thailand breast biopsy devices market, by product 2021-2033 (USD Million)
Table 82 Thailand breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 83 Thailand breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 84 Thailand breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 85 Latin America breast biopsy devices market, by region 2021-2033 (USD Million)
Table 86 Latin America breast biopsy devices market, by product 2021-2033 (USD Million)
Table 87 Latin America breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 88 Latin America breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 89 Latin America breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 90 Brazil breast biopsy devices market, by product 2021-2033 (USD Million)
Table 91 Brazil breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 92 Brazil breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 93 Brazil breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 94 Argentina breast biopsy devices market, by product 2021-2033 (USD Million)
Table 95 Argentina breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 96 Argentina breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 97 Argentina breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 98 MEA breast biopsy devices market, by region 2021-2033 (USD Million)
Table 99 MEA breast biopsy devices market, by product 2021-2033 (USD Million)
Table 100 MEA breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 101 MEA breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 102 MEA breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 103 South Africa breast biopsy devices market, by product 2021-2033 (USD Million)
Table 104 South Africa breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 105 South Africa breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 106 South Africa breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 107 Saudi Arabia breast biopsy devices market, by product 2021-2033 (USD Million)
Table 108 Saudi Arabia breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 109 Saudi Arabia breast biopsy devices market, by guidance technology (USD Million)
Table 110 Saudi Arabia breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 111 UAE breast biopsy devices market, by product 2021-2033 (USD Million)
Table 112 UAE breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 113 UAE breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 114 UAE breast biopsy devices market, by end use 2021-2033 (USD Million)
Table 115 Kuwait breast biopsy devices market, by product 2021-2033 (USD Million)
Table 116 Kuwait breast biopsy devices market, by procedure 2021-2033 (USD Million)
Table 117 Kuwait breast biopsy devices market, by guidance technology 2021-2033 (USD Million)
Table 118 Kuwait breast biopsy devices market, by end use 2021-2033 (USD Million)
List of Figures
Figure 1 Breast biopsy devices market segmentation.
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing.
Figure 7 Market snapshot
Figure 8 Segment snapshot.
Figure 9 Competitive landscape snapshot
Figure 10 Breast biopsy devices - market size and growth prospects (USD Million)
Figure 11 Breast biopsy devices market: Industry Value Chain Analysis
Figure 12 Breast biopsy devices market: Market Dynamics
Figure 13 Breast biopsy devices market: PORTER’s Analysis
Figure 14 Breast biopsy devices market: PESTEL Analysis
Figure 15 Breast biopsy devices market share by product, 2025 & 2033 (USD Million)
Figure 16 Breast biopsy devices market, by product: market share, 2025 & 2033.
Figure 17 Biopsy guidance systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 Biopsy drivers & handpieces market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 Automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 Semi-automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Biopsy tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 24 Prone tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 25 Upright/add-on tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 26 Biopsy consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 27 Needles & probes market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 28 Site markers & clips market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 29 By shape/design market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 30 Standard geometric markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 31 Ring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 32 Cross market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 33 Others market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 34 Advanced anchoring markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 35 Anchor market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 36 Wing, "U" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 37 "Q" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 38 3D / expandable markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 39 3D ribbon market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 40 3D sphere market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 41 3D mesh market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 42 Localization systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 43 Traditional wires market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 45 Other consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 Breast biopsy devices market share by procedure, 2025 & 2033 (USD Million)
Figure 47 Breast biopsy devices market, by procedure: market share, 2025 & 2033.
Figure 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 Core needle biopsy (CNB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 51 Surgical (open) biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 52 Liquid biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 53 Breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
Figure 54 Breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
Figure 55 Ultrasound-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 56 Mammography / stereotactic-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 57 MRI-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 58 Breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
Figure 59 Breast biopsy devices market, by end use: market share, 2025 & 2033.
Figure 60 Hospitals market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 62 Specialized breast care centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 64 Regional marketplace: key takeaways
Figure 65 North America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 U.S. breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Canada breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Mexico breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Europe breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 UK breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Germany breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 72 France breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 73 Italy breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 74 Spain breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 75 Sweden breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 76 Denmark breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 77 Norway breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 78 Asia Pacific breast biopsy devices market estimates and forecast, 2021-2033 (USD Million)
Figure 79 China breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Japan breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 India breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 South Korea breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Australia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Thailand breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Latin America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Brazil breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Argentina breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 MEA breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 89 South Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Saudi Arabia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 91 UAE breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Kuwait breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 93 Key company categorization
Figure 94 Company market positioning
Figure 95 Key company market share analysis, 2025
Figure 96 Strategic framework
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Data analysis models
Figure 5 Market formulation and validation
Figure 6 Data validating & publishing.
Figure 7 Market snapshot
Figure 8 Segment snapshot.
Figure 9 Competitive landscape snapshot
Figure 10 Breast biopsy devices - market size and growth prospects (USD Million)
Figure 11 Breast biopsy devices market: Industry Value Chain Analysis
Figure 12 Breast biopsy devices market: Market Dynamics
Figure 13 Breast biopsy devices market: PORTER’s Analysis
Figure 14 Breast biopsy devices market: PESTEL Analysis
Figure 15 Breast biopsy devices market share by product, 2025 & 2033 (USD Million)
Figure 16 Breast biopsy devices market, by product: market share, 2025 & 2033.
Figure 17 Biopsy guidance systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 18 Biopsy drivers & handpieces market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 19 Vacuum-assisted biopsy (VAB) drivers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 20 Core needle biopsy (CNB) guns market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 21 Automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 22 Semi-automated market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 23 Biopsy tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 24 Prone tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 25 Upright/add-on tables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 26 Biopsy consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 27 Needles & probes market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 28 Site markers & clips market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 29 By shape/design market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 30 Standard geometric markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 31 Ring market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 32 Cross market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 33 Others market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 34 Advanced anchoring markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 35 Anchor market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 36 Wing, "U" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 37 "Q" shape market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 38 3D / expandable markers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 39 3D ribbon market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 40 3D sphere market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 41 3D mesh market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 42 Localization systems market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 43 Traditional wires market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 44 Wireless seeds-RFID/magnetic market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 45 Other consumables market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 46 Breast biopsy devices market share by procedure, 2025 & 2033 (USD Million)
Figure 47 Breast biopsy devices market, by procedure: market share, 2025 & 2033.
Figure 48 Vacuum-assisted biopsy (VAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 49 Core needle biopsy (CNB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 50 Fine needle aspiration biopsy (FNAB) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 51 Surgical (open) biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 52 Liquid biopsy market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 53 Breast biopsy devices market share by guidance technology, 2025 & 2033 (USD Million)
Figure 54 Breast biopsy devices market, by guidance technology: market share, 2025 & 2033.
Figure 55 Ultrasound-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 56 Mammography / stereotactic-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 57 MRI-guided market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 58 Breast biopsy devices market share by end use, 2025 & 2033 (USD Million)
Figure 59 Breast biopsy devices market, by end use: market share, 2025 & 2033.
Figure 60 Hospitals market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 61 Ambulatory surgical centers (ASCs) market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 62 Specialized breast care centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 63 Diagnostic centers/imaging centers market estimates & forecasts, 2021-2033 (Revenue, USD Million)
Figure 64 Regional marketplace: key takeaways
Figure 65 North America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 U.S. breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Canada breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 68 Mexico breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Europe breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 UK breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Germany breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 72 France breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 73 Italy breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 74 Spain breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 75 Sweden breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 76 Denmark breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 77 Norway breast biopsy devices market estimates and forecasts 2021-2033 (USD Million)
Figure 78 Asia Pacific breast biopsy devices market estimates and forecast, 2021-2033 (USD Million)
Figure 79 China breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 80 Japan breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 India breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 82 South Korea breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Australia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 84 Thailand breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 85 Latin America breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 86 Brazil breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 87 Argentina breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 88 MEA breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 89 South Africa breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 90 Saudi Arabia breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 91 UAE breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 92 Kuwait breast biopsy devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 93 Key company categorization
Figure 94 Company market positioning
Figure 95 Key company market share analysis, 2025
Figure 96 Strategic framework
Companies Mentioned
The leading players profiled in this Breast Biopsy Devices market report include:- Hologic, Inc.
- Mammotome (Danaher)
- BD
- Argon Medical
- Merit Medical Systems
- GE HealthCare
- Cook Medical
- MOLLI Surgical (Stryker)
- Planmed Oy
- Metaltronica Spa
- Trivitron Healthcare
- Siemens Healthineers
- Fujifilm Healthcare
- INRAD
- SteryLab
- Resitu Medical
- TransMed7, LLC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | February 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 3.52 Billion |
| Forecasted Market Value ( USD | $ 5.6 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
